Difference between revisions of "Team:ETH Zurich/Safety"
(One intermediate revision by one other user not shown) | |||
Line 225: | Line 225: | ||
<p>It is never too early to think ahead what might happen if our MicroBeacon project is further developed and commercially used as a cancer diagnosis kit. | <p>It is never too early to think ahead what might happen if our MicroBeacon project is further developed and commercially used as a cancer diagnosis kit. | ||
− | Since one component of the kit are live bacteria, | + | Since one component of the kit are live bacteria, special care has to be taken in a clinical environment.</p> |
<table> | <table> | ||
Line 236: | Line 236: | ||
<tr> | <tr> | ||
− | <td><b>E.coli infection</b></td> | + | <td><b><i>E.coli</i> infection</b></td> |
<td> | <td> | ||
<img src="https://static.igem.org/mediawiki/2015/7/71/RiskE4.png" width="70%"> | <img src="https://static.igem.org/mediawiki/2015/7/71/RiskE4.png" width="70%"> | ||
Line 242: | Line 242: | ||
<td> | <td> | ||
<ul> | <ul> | ||
− | <li><p>Keep MicroBeacons away from | + | <li><p>Keep MicroBeacons away from patients: Collect blood sample and do the test experiment in a seperate room.</p> |
</li> | </li> | ||
<li><p>After use autoclave waste and destroy remaining blood sample or store in a safe container.</p> | <li><p>After use autoclave waste and destroy remaining blood sample or store in a safe container.</p> |
Latest revision as of 01:24, 19 September 2015
- Project
- Modeling
- Lab
- Human
Practices - Parts
- About Us
General Safety Considerations
Method of Safety Evaluation
To manage the risks associated with the development of our MicroBeacon CTC detection system we used the following scheme to evaluate possible adverse scenarios and the effectiveness of countermeasures:
Preventive measures can either serve to decrease the likelihood (x-axis) or the severity (y-axis) of a potential scenario or both. The goal is to move the risks as far as possible into the green corner.
Working at the ETH Zurich Labs
Responsible conduct during everyday lab hours is parmount for the prevention of accidents. Every new person in the ETH D-BSSE lab must undergo safety training instructed by a Technical Manager. No exception was made for our iGEM team. Though much of it is common sense and our work was restricted to Biosafety Level 1, there is still a lot that can go wrong. Here are a few examples:
Possible Scenario | Old Risk | Countermeasures | New Risk |
Accidental poisoning |
|
||
My E. coli are on fire! |
Since we use Bunsen burners to create a semi-sterile working environment it is quite likely that something catches fire. |
||
I spilled and entire bottle of ethidium bromide on my lab coat! |
|
||
I forgot to put my goggles on and now I have sulphuric acid in my eye! |
|
||
Dangerous equipment |
|
Handling Genetically Modified Organisms
Our MicroBeacon E. coli cells do not express any toxic substances and the fact that they prefer temperatures around 37 °C makes it unlikely that they survive for a long time when accidentally released. However, as they are genetically modified they might still harbor a potential and unforseen risk to the environment.
Possible Scenario | Old Risk | Countermeasures | New Risk |
E.coli infection |
|
||
E.coli released into environment |
|
Using our MicroBeacon CTC Detection System for Medical Diagnosis
It is never too early to think ahead what might happen if our MicroBeacon project is further developed and commercially used as a cancer diagnosis kit. Since one component of the kit are live bacteria, special care has to be taken in a clinical environment.
Possible Scenario | Old Risk | Countermeasures | New Risk |
E.coli infection |
|
||
False positive test result |
Consider the ethical implications of diagnosing cancer metastasis in a healthy individual. |
||
Production error |
On the side of the manufacturer: consider the finanial risk and possible damage to the company's reputation |